Yusuf, S., Teo, K.K., Pogue, J., Dyal, L., Copland, I., Schumacher, H., Dagenais, G., Sleight, P. and Anderson, C. (2008) Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. The New England Journal of Medicine, 358, 1547-1559.
http://dx.doi.org/10.1056/NEJMoa0801317

has been cited by the following article:

• TITLE: Prevalence and Characteristics of Treatment-Resistant Hypertension among Hypertensive Japanese Outpatients

  AUTHORS: Keisuke Okamura, Hidenori Urata

  KEYWORDS: Treatment-Resistant Hypertension, Catheter-Based Renal Sympathetic Denervation, Human

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.6 No.9, September 10, 2015

  ABSTRACT: Aims: To retrospectively investigate the prevalence and characteristics of treatment-resistant hypertension (R-HT) among consecutive hypertensive outpatients, since patients with R-HT are candidates for catheter-based renal sympathetic denervation (RD). Methods: Consecutive hypertensive outpatients (n = 999) were recruited in our hospital. R-HT patients who were candidates for RD had clinic systolic blood pressure > 160 mmHg despite taking three or more antihypertensive drugs including at least one diuretics at higher than standard doses. Results: Our survey indicated that only 26 patients (2.6%) were potential candidates for renal denervation. Candidates for RD showed a significantly higher age (P